Page last updated: 2024-08-26

bosentan anhydrous and Alzheimer Disease

bosentan anhydrous has been researched along with Alzheimer Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prakash, A; Singh, M1
Bonetti, PO; Elesber, AA; Lerman, A; Lerman, LO; Woodrum, JE; Younkin, SG; Zhu, XY1

Other Studies

2 other study(ies) available for bosentan anhydrous and Alzheimer Disease

ArticleYear
Possible role of endothelin receptor against hyperhomocysteinemia and β-amyloid induced AD type of vascular dementia in rats.
    Brain research bulletin, 2017, Volume: 133

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Bosentan; Brain; Dementia; Dementia, Vascular; Endothelins; Endothelium, Vascular; Hyperhomocysteinemia; Lipid Peroxidation; Male; Maze Learning; Memory; Methionine; Mitochondria; Oxidative Stress; Rats; Rats, Wistar; Receptors, Endothelin; Sulfonamides

2017
Bosentan preserves endothelial function in mice overexpressing APP.
    Neurobiology of aging, 2006, Volume: 27, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelium, Vascular; Female; Mice; Mice, Inbred C57BL; Mice, Transgenic; Sulfonamides; Vasodilation

2006